Adage Capital Partners’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$10.4M | – | 749 |
|
|
2020
Q2 | $10.4M | Sell |
50,000
-130,000
| -72% | -$27.1M | 0.03% | 517 |
|
|
2020
Q1 | $17.6M | Buy |
180,000
+80,000
| +80% | +$7.82M | 0.05% | 351 |
|
|
2019
Q4 | $11.5M | Hold |
100,000
| – | – | 0.03% | 517 |
|
|
2019
Q3 | $5.45M | Sell |
100,000
-200,000
| -67% | -$10.9M | 0.01% | 621 |
|
|
2019
Q2 | $35.7M | Hold |
300,000
| – | – | 0.09% | 257 |
|
|
2019
Q1 | $15.7M | Hold |
300,000
| – | – | 0.04% | 442 |
|
|
2018
Q4 | $9.45M | Hold |
300,000
| – | – | 0.03% | 518 |
|
|
2018
Q3 | $18.2M | Sell |
300,000
-100,000
| -25% | -$6.05M | 0.04% | 423 |
|
|
2018
Q2 | $21.2M | Buy |
400,000
+50,000
| +14% | +$2.65M | 0.05% | 384 |
|
|
2018
Q1 | $20.3M | Buy |
350,000
+100,000
| +40% | +$5.8M | 0.05% | 392 |
|
|
2017
Q4 | $8.75M | Buy |
250,000
+50,000
| +25% | +$1.75M | 0.02% | 584 |
|
|
2017
Q3 | $7.3M | Hold |
200,000
| – | – | 0.02% | 595 |
|
|
2017
Q2 | $5M | Buy |
+200,000
| New | +$5M | 0.01% | 634 |
|
|
2015
Q1 | – | Sell |
-64,955
| Closed | -$35.1M | – | 707 |
|
|
2014
Q4 | $35.1M | Sell |
64,955
-8,166
| -11% | -$4.41M | 0.09% | 288 |
|
|
2014
Q3 | $25M | Buy |
+73,121
| New | +$25M | 0.06% | 339 |
|